Unlaminated Plastics Profile Shape Manufacturing (U.S.) — NAICS 326121

1. Overview

This is the business of pushing molten plastic through a shaped die to make long, continuous, non-rigid (flexible) cross-sections — rod, tube, and specialty profiles — that are then cut to length. In plain terms: flexible plastic tubing (medical, lab, and industrial), plastic rod and machinable stock shapes, sausage casings, and soft trim and seal profiles. The defining process is profile extrusion, and the category is deliberately narrow: it is unlaminated (no bonded layers) and non-rigid.[1][2]

The production line is continuous: resin pellets, dry blend, regrind, colorants, and additives enter a heated screw extruder; the screw melts, mixes, and pressurizes the polymer and forces it through a profile-specific die. The hot shape is held to tolerance in a water-cooled or vacuum calibration unit, pulled at a controlled rate, then cut, wound, or subjected to in-line drilling, punching, printing, or assembly. Die balance, melt temperature, pressure, cooling, and puller alignment determine wall thickness, straightness, and scrap.[3][4]

Why an investor cares: the low end (commodity flexible PVC (polyvinyl chloride) profile and trim) is a thin-margin, resin-cost-driven manufacturing grind, but the high end — precision medical tubing for catheters, IV (intravenous) lines and minimally invasive devices — is a high-margin, structurally growing, hard-to-qualify business. The two ends of the same NAICS code behave like different industries.

Public vs. private ways in: there is effectively no U.S.-listed pure play. Public exposure comes only through diversified or foreign-listed groups where tubing/profile is one slice (Saint-Gobain, Nordson, Trelleborg, Viscofan). The economic center of gravity sits in private, private-equity-owned extruders — the flagship being Zeus, sold to buyout firm EQT in 2024 in a deal valued at about $3.4 billion.[5][6]

2. What it is and how it's structured

Scope (in this code): establishments that convert plastics resins into non-rigid plastics profile shapes — rod, tube, and sausage casings, plus soft/flexible extruded profiles.[1][2] Plastic sausage casings are heat-resistant, normally non-edible tubes used to form sausages during cooking and removed afterward.[7] Products include flexible PVC and polyurethane tubing, medical and laboratory tubing, high-performance fluoropolymer tubing (PTFE (polytetrafluoroethylene), FEP, PFA), plastic rod and machinable stock shapes, and plastic sausage casings.

What it explicitly excludes (named adjacent NAICS codes):

• Plastics pipe and pipe fittings → 326122 (rigid pressure pipe is a separate, larger industry).
• Film, unlaminated sheet, and bags → 32611 (Plastics Packaging Materials and Unlaminated Film and Sheet).[2]
• Rubber and plastics hoses and belting → 326220.[2]
• Laminated plates, sheet, and shapes → 326130.
• Rigid profile shapes — including rigid vinyl (PVC) window and door profiles and vinyl siding — are not in 326121. That activity generally sits under "all other plastics product" (326199) and inside building-products (fenestration/siding) companies. This is the single most common misconception about the code: the vinyl window and siding "profile" business most people picture is largely outside 326121.

The classification is narrower than the phrase "plastic extrusion industry." Extrusion is also used to make pipe, hose, film, sheet, wire coating, and many products assigned elsewhere in NAICS. Market studies that combine all extruded plastics materially overstate the addressable market for 326121.

Ownership mix: privately held mid-size manufacturers and PE-owned roll-ups dominate. A handful of large specialists (medical tubing, casings) sit at the top; a long tail of small custom extrusion shops fills the middle and bottom.

3. How big it is

Federal statistics for NAICS 326121 (U.S.):

So this is a genuine mid-size manufacturing industry — real plants, real capital, roughly $27 million of shipments per establishment — not a sector dominated by government or by tiny sole operators. The federal figures are a fair count of the code.

The undercount that matters here is definitional, not demographic. Because rigid vinyl window/door profiles and siding sit in other codes, and because much tube/profile extrusion is done in-house by medical-device and automotive firms (and counted under their primary codes), the $9.0 billion understates the broader "extruded plastic profile" economy as a layperson imagines it. Read 326121 as the merchant market for non-rigid rod, tube, and casings — accurate for what it measures, narrower than the everyday phrase "plastic profiles."

4. The investable universe

There is no U.S.-listed pure-play in this code. The cleanest public exposures are diversified or foreign-listed, where in-scope products are one line among many.

Public companies with meaningful (but partial) exposure:

Private / PE-owned players (the real center of gravity):

For comparison, the adjacent rigid-vinyl/fenestration world (not in 326121) does have U.S.-listed names — e.g. Quanex Building Products (NYSE: NX), which reported $1.84 billion in FY2025 net sales after buying Tyman.[16] Quanex's Extruded Solutions segment reported fiscal 2024 sales of $560 million and operating income of $87 million (a 16% operating margin); fiscal 2025 sales were $647 million with a 6% operating margin, reflecting a $55 million goodwill impairment and acquisition effects.[16] Investors reaching for "plastic profile" exposure often end up here by accident; it is a different code and a different demand cycle.

Other adjacent public exposures: Westlake Corporation (NYSE: WLK) supplies PVC resin and owns downstream pipe, fittings, compounds, siding, and window-related building products — offering vertical PVC-chain exposure rather than a pure 326121 position.[17] Trex (Nasdaq: TREX) makes composite decking from a blend of reclaimed wood fiber and recycled polyethylene film, an extrusion-adjacent play.[18] James Hardie (NYSE: JHX) obtained PVC/composite decking and trim exposure when it completed its acquisition of AZEK on July 1, 2025; AZEK is no longer a standalone public equity.[19]

5. How the money works

Owners in this industry make money on throughput, mix, and the resin-to-price spread — not on any single product.

• Line utilization. Extrusion lines are capital assets that must run as close to 24/7 as possible. Uptime, line speed, fast die changeovers, and low scrap (regrind reuse) are the operating levers. Idle line time is lost margin. High fixed overhead makes utilization critical: Quanex disclosed consolidated machine-capacity utilization of approximately 58% in fiscal 2025, illustrating the leverage when lines run fuller.[16]
• Resin cost and pass-through. Plastic resin (PVC, polyethylene, polypropylene, and pricier engineering/fluoropolymers) is the single largest input cost. Commodity resin prices swing with oil, ethylene, and chlorine; in 2025 they sat in a soft, "buyer's market" range, with Westlake announcing the shutdown of a PVC plant in December 2025 to tighten supply.[20][21] Profitable extruders pass resin moves through via indexed contracts or surcharges; a lag in pass-through squeezes margin when resin spikes. Quanex notes that most customer arrangements pass PVC changes through using published indices, but with timing lags that leave short-term exposure, and that inflation in raw materials, labor, freight, and overhead was not fully recovered in fiscal 2025 or 2024.[16]
• Output pricing can rise even while volume weakens. The BLS producer-price index for unlaminated plastic profile shapes increased from 232.9 in May 2025 to 255.9 in May 2026 — roughly 9.9% — an output-price measure that reflects cost pass-through, not necessarily volume or margin gains.[22]
• Tooling economics as a moat. Custom dies are often paid for by the customer and tuned to that customer's part. Once a die is qualified, switching suppliers is costly — which is why custom extrusion relationships are sticky.
• Mix is everything. Commodity flexible PVC profile and trim earn thin margins. Engineered and medical tubing — tight-tolerance, multi-layer, micro-bore, fluoropolymer — earns far more, because it requires cleanrooms, validated processes, and long customer qualification cycles that few shops can pass. The valuation gap is stark: Zeus, a fluoropolymer medical-tubing specialist, changed hands at roughly 17x revenue (~$3.4B on ~$200M sales), a multiple only a regulated, high-barrier product mix can command.[5][6]
• Value-added secondary work. Printing, tipping, coiling, cutting, cleanroom packaging, and sub-assembly lift a commodity extrusion into a device-ready component and lift the margin with it.

The practical read: the same NAICS code contains a low-margin, cyclical, resin-driven commodity business and a high-margin, defensive, certification-gated medical business. Where an owner sits on that spectrum decides the returns.

6. What drives demand

• Medical devices (the growth engine). Aging populations and the shift to minimally invasive procedures drive catheter and tubing volume. The fluoropolymer tubing market alone was estimated at about $622 million in 2025, growing to ~$813 million by 2030 (~5.5% a year), with broader medical tubing and micro-extrusion segments cited growing faster still (high-single to low-double digits).[23][9] This portion is largely non-cyclical.
• Construction and remodeling. Flexible trim, seals, weatherstrip, and tubing track housing starts and renovation. This portion is cyclical and was soft in 2025 on weak construction demand.[20][21] Census reported May 2026 U.S. housing starts at a seasonally adjusted annual rate of 1.177 million, 8.7% below May 2025, demonstrating the cyclical pressure on building-oriented extruders.[24]
• Energy efficiency and window replacement. Replacement demand is supported by an aging housing stock, homeowner equity, and energy-efficiency requirements. Vinyl and composite frames offer better thermal resistance than metal frames.[25] ENERGY STAR's current residential-window specification became effective October 23, 2023; the program estimates replacing single-pane windows with certified products can reduce household energy bills by up to 13% nationally.[26] More demanding thermal standards favor multi-chamber vinyl profiles, insulating inserts, co-extruded seals, and more complex profile designs.
• Automotive and industrial. Seals, fluid tubing, and trim ride vehicle build rates and factory output.
• Food. Sausage casings track processed-meat consumption — steady, defensive demand.[10]
• Reshoring. Onshoring of medical-supply-chain manufacturing is a tailwind for domestic precision extruders (a forward-looking, not yet fully realized, driver).

7. Regulation

• Medical/FDA. Tubing for medical use must meet FDA (Food and Drug Administration) requirements, USP (U.S. Pharmacopeia) Class VI biocompatibility, and ISO 13485 quality systems, typically produced in cleanrooms with validated processes. These rules are a barrier to entry — and the moat behind medical-grade margins.
• Food-contact. Sausage casings and food-grade tubing fall under FDA food-contact rules and USDA/FSIS oversight.
• Chemical regulation (a live risk). EPA (Environmental Protection Agency) designated vinyl chloride — the feedstock for PVC — a High-Priority Substance for TSCA (Toxic Substances Control Act) risk evaluation in December 2024, publishing a draft scope in January 2025.[27] Separately, EPA is running risk evaluations of phthalate plasticizers (DEHP and others) that make flexible PVC soft; a DEHP evaluation was released in December 2025, and EPA has preliminarily found unreasonable worker risk for a related phthalate.[28] These reviews could restrict the flexible-PVC tubing chemistry over time.
• PFAS. Fluoropolymer tubing (PTFE, FEP, PFA) is caught up in the tightening regulatory net around PFAS (per- and polyfluoroalkyl substances). This is a genuine forward risk to the highest-margin medical segment, forcing material audits and possible substitutions.[9]
• Plastic pollution and pellet loss. EPA's 2024 National Strategy to Prevent Plastic Pollution contemplates regulatory review of plastic-production facilities, pellet transport, and additives.[29] Plastic pellets also create Clean Water Act exposure: EPA states that plastic manufacturers discharging industrial stormwater require permits and controls to prevent pellets, flakes, and powders from reaching waterways.[30]
• Worker safety and air. OSHA identifies moving parts, nip points, high voltage, hot surfaces, fumes, and spilled pellets as significant plastics-processing hazards; lockout/tagout, guarding, ventilation, and housekeeping are recurring compliance requirements.[31] California Proposition 65 warnings apply to some PVC/phthalate products.

8. Competitive dynamics and consolidation

The industry is fragmented in the middle, concentrated at the top. Of 265 firms, the four largest account for 41.1% of shipments, the top 8 for 49.9%, the top 20 for 66.1%, and the top 50 for 83.5% — meaning roughly 215 smaller firms split the remaining ~16%.[1] (The Herfindahl-Hirschman Index is suppressed in the federal data, so precise overall concentration isn't published.)[1]

Consolidation is active and PE-led. Private-equity buyers have been rolling up custom extruders (Pexco under Odyssey; Tekni-Plex under Genstar) and paying premium multiples for the medical crown jewels (EQT's ~$3.4B Zeus deal).[5][6][12][11] Barriers to entry rise steeply with product sophistication: anyone can extrude commodity profile, but cleanroom-qualified, tight-tolerance medical tubing takes years of customer qualification and capital. Import competition is real at the commodity end but muted for custom, bulky, just-in-time, or regulated parts, which favor domestic suppliers.

9. Risks

• Resin price volatility compresses margins when pass-through lags.[20][21]
• Construction/auto cyclicality hits the commodity-profile end.
• Chemical regulation — vinyl chloride and phthalate TSCA reviews (flexible PVC) and PFAS restrictions (fluoropolymers) threaten the two most important material families in the code.[27][28][9]
• Substitution risk cuts both ways. Plastics displace wood, aluminum, rubber, and metal, but fiberglass, aluminum, wood composites, paper-based materials, and redesigned products can displace plastic. Public concern about plastic waste may accelerate recycled-content mandates, producer-responsibility fees, pellet-loss rules, and customer material redesign.[29]
• Customer concentration — medical extruders often depend on a few large device OEMs (original equipment manufacturers). Custom tooling and validation improve retention, but losing one high-volume OEM program can strand dedicated die and line capacity.
• Import substitution at the commodity end.
• Execution/EHS — extrusion plants carry fire, dust, and worker-exposure risk.[31]
• No liquid public pure-play — public investors cannot cleanly own the best part of this industry.

10. How to invest and the outlook

Public routes are indirect. The nearest exposures are diversified/foreign-listed groups where tubing or casings are one line: Saint-Gobain (SGO), Nordson (NDSN), Trelleborg (TREL), and Viscofan (VIS) for casings.[10][9] None gives a clean, sizeable read on 326121; each dilutes the theme across unrelated businesses. Investors who want the rigid vinyl-profile building-products cycle (a different code) can look at names like Quanex (NX) — but that is fenestration, not this industry.[16]

Private routes are where the industry actually trades. This is a staple hunting ground for private equity and strategic buyers — buy a custom or medical extruder, professionalize operations, bolt on smaller shops, and re-rate the mix toward medical. The premium multiples paid for medical extrusion (Zeus) reflect that playbook.[5][6] For private investors, the value creation is in mix shift (commodity → medical/engineered), utilization, and roll-up scale. The diligence focus should be revenue by end market and customer, resin pass-through terms, die ownership, qualification-transfer restrictions, line utilization, scrap, maintenance capital, environmental permits, and whether stated EBITDA depends on temporarily favorable resin timing.

Near-term drivers (forward-looking): medical-tubing and micro-extrusion demand should keep growing on aging demographics and minimally invasive procedures;[23][9] commodity-profile volume hinges on a construction recovery that was still soft in 2025;[20][21] and the swing factor over the medium term is regulation — how hard EPA lands on vinyl chloride, phthalates, and PFAS will shape which material chemistries, and which margins, survive.[27][28] The likely path is continued consolidation, with the premium accruing to whoever owns the regulated, high-tolerance medical end — and the commodity end remaining a resin-cost-driven grind.

---

Sources

1. U.S. Census Bureau, 2022 Economic Census (receipts, firms, concentration ratios) and County Business Patterns 2023 (establishments, employment, payroll), NAICS 326121, 2022–2023. https://data.census.gov/
2. NAICS Association, "NAICS Code 326121 — Unlaminated Plastics Profile Shape Manufacturing" (definition and cross-references), 2022. https://www.naics.com/naics-code-description/?v=2022&code=326121
3. Society of Plastics Engineers, "Extrusion Process" (process description), 2025. https://www.4spe.org/i4a/pages/index.cfm?pageID=9492
4. British Plastics Federation, "Extrusion" (process description), 2025. https://www.bpf.co.uk/plastipedia/processes/Extrusion.aspx
5. PR Newswire / EQT, "EQT Private Equity to acquire Zeus, a global leader in advanced polymer components," 2023. https://www.prnewswire.com/news-releases/eqt-private-equity-to-acquire-zeus-a-global-leader-in-advanced-polymer-components-used-in-life-saving-medical-procedures-302017955.html
6. SC Biz News, "Orangeburg medical device manufacturer Zeus acquired in $3B deal," 2023. https://scbiz.com/orangeburg-based-medical-device-manufacturer-zeus-acquired-in-3b-deal/
7. USDA Agricultural Marketing Service, "Collagen and Gel Casings" (technical document on plastic vs. other casings), 2020. https://www.ams.usda.gov/sites/default/files/media/CollagenGelPetition.pdf
8. U.S. Small Business Administration, Table of Small Business Size Standards (NAICS 326121 = 600 employees), 2023. https://www.sba.gov/document/support-table-size-standards
9. MarketsandMarkets, "Medical Plastics Tubing Market — Leading Players" (Saint-Gobain, Nordson, Freudenberg Medical, Trelleborg, W.L. Gore; PFAS note; Nordson–Atrion 2024), 2025. https://www.marketsandmarkets.com/ResearchInsight/medical-plastics-tubing-companies.asp
10. Wikipedia, "Viscofan" (global sausage-casing leader; cellulose, collagen, fibrous, plastic), 2025. https://en.wikipedia.org/wiki/Viscofan
11. Plastics News, "Report: Private equity firm buying Tekni-Plex for $1.5 billion" (Genstar Capital), 2017. https://www.plasticsnews.com/article/20170904/NEWS/170909978/report-private-equity-firm-buying-tekni-plex-for-1-5-billion
12. Business Wire, "Pexco LLC Acquires Plastic Profiles" (Odyssey Investment Partners ownership), 2022. https://www.businesswire.com/news/home/20221102006036/en/Pexco-LLC-Acquires-Plastic-Profiles
13. Pexco, "About Us — Company History" (acquisition history, employee count), 2025. https://www.pexco.com/about-us/
14. REHAU, "About REHAU" (corporate profile), 2025. https://www.rehau.com/us-en/about-rehau
15. REHAU, "Window Extrusion" (North American profile operations), 2025. https://www.rehau.com/us-en/windows/manufacturers
16. Quanex Building Products, Form 10-K (fiscal year ended October 31, 2025), 2025. https://www.sec.gov/Archives/edgar/data/1423221/000142322125000100/nx-20251031.htm
17. Westlake Corporation, Form 10-K (fiscal year ended December 31, 2025), 2026. https://www.sec.gov/Archives/edgar/data/1262823/000126282326000016/wlk-20251231.htm
18. Trex Company, Form 10-K (fiscal year ended December 31, 2024), 2025. https://www.sec.gov/Archives/edgar/data/1069878/000095017025025780/trex-20241231.htm
19. James Hardie Industries, "James Hardie Completes Acquisition of AZEK" (July 1, 2025), 2025. https://ir.jameshardie.com/news/news-details/2025/James-Hardie-Completes-Acquisition-of-AZEK-to-Become-a-Leading-Provider-of-Exterior-Home-and-Outdoor-Living-Solutions/default.aspx
20. Plastics Technology, "December 2025: Lower Prices for PE, PP, PS and PVC; PET Higher," 2025. https://www.ptonline.com/articles/december-2025-lower-prices-for-pe-pp-ps-and-pvc-pet-higher
21. S&P Global, "Commodities 2026: Global 2026 PVC on the edge of production cuts and trade flow twists," 2025. https://www.spglobal.com/energy/en/news-research/latest-news/chemicals/122325-commodities-2026-global-2026-pvc-on-the-edge-of-production-cuts-and-trade-flow-twists
22. Federal Reserve Bank of St. Louis (FRED), "Producer Price Index: Unlaminated Plastic Profile Shapes," series PCU3261213261210, May 2025–May 2026. https://fred.stlouisfed.org/data/PCU3261213261210
23. MarketsandMarkets, "Fluoropolymer Tubing Market worth $813.5 million by 2030," 2025. https://www.prnewswire.com/news-releases/fluoropolymer-tubing-market-worth-813-5-million-by-2030---exclusive-report-by-marketsandmarkets-302568018.html
24. U.S. Census Bureau, "New Residential Construction" (housing starts, May 2026), 2026. https://www.census.gov/construction/nrc/current/
25. U.S. Department of Energy, "Window Types and Technologies," 2025. https://www.energy.gov/energysaver/window-types-and-technologies
26. ENERGY STAR, "Residential Windows, Doors, and Skylights," 2025. https://www.energystar.gov/products/res_windows_doors_skylights
27. U.S. EPA, "Risk Evaluation for Vinyl Chloride" (High-Priority designation Dec 2024; draft scope Jan 2025), 2025. https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/risk-evaluation-vinyl-chloride
28. U.S. EPA, "EPA Announces Schedule for TSCA Risk Evaluations of Phthalates" and "Risk Evaluation for Diethylhexyl Phthalate (DEHP)," 2024–2025. https://www.epa.gov/chemicals-under-tsca/epa-announces-schedule-tsca-risk-evaluations-phthalates
29. U.S. EPA, "National Strategy to Prevent Plastic Pollution," 2024. https://www.epa.gov/circulareconomy/national-strategy-prevent-plastic-pollution
30. U.S. EPA, "EPA Requires Two Los Angeles Area Plastics Manufacturers to Protect Local Waterways" (Clean Water Act pellet enforcement), 2015. https://www.epa.gov/archive/epa/newsreleases/us-epa-requires-two-los-angeles-area-plastics-manufacturers-protect-local-waterways.html
31. OSHA, "Plastics Industry — Hazards and Solutions," 2025. https://www.osha.gov/plastic-industry/hazards-solutions